Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment?
Vittal P, Pulliam CL, Goetz CG, Ouyang B, Jankovic J, Ramirez-Castaneda JL, Heldman DA.
Mov Disord Clin Pract. 2017 Oct 25;5(1):96-98. doi: 10.1002/mdc3.12554. eCollection 2018 Jan-Feb. No abstract available.
Similar articles
ASFMR1 splice variant: A predictor of fragile X-associated tremor/ataxia syndrome.
Vittal P, Pandya S, Sharp K, Berry-Kravis E, Zhou L, Ouyang B, Jackson J, Hall DA.
Neurol Genet. 2018 Jul 27;4(4):e246. doi: 10.1212/NXG.0000000000000246. eCollection 2018 Aug.
Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
Fraint A, Vittal P, Comella C.
Ther Clin Risk Manag. 2016 Feb 5;12:147-54. doi: 10.2147/TCRM.S99239. eCollection 2016. Review.
BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome Sequencing.
Vittal P, Hall DA, Dames S, Mao R, Berry-Kravis E.
Mov Disord Clin Pract. 2015 Oct 28;3(2):197-199. doi: 10.1002/mdc3.12250. eCollection 2016 Mar-Apr. No abstract available.
New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype.
Fraint A, Vittal P, Szewka A, Bernard B, Berry-Kravis E, Hall DA.
Front Genet. 2014 Oct 17;5:365. doi: 10.3389/fgene.2014.00365. eCollection 2014.
Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone.
Prabhu R, Vittal P, Yin Q, Flemington E, Garry R, Robichaux WH, Dash S.
J Med Virol. 2005 Aug;76(4):511-9.
Time-dependent barriers and first-passage times--different types of neuronal models.
Vasudevan R, Vittal PR.
Neurol Res. 1982;4(1-2):63-87.
Neuronal spike trains with exponential decay.
Vasudevan R, Vittal PR, Vijayakumar A.
Neurol Res. 1981;3(2):139-66.
Filters: Manage Filters